A highly convergent synthesis of an N-linked glycopeptide presenting the H-type 2 human blood group determinant

Tetrahedron

Volumn 62, Issue 20, 2006, Pages 4954-4978

  Wang, Zhi Guang ^a   Warren, J David ^a   Dudkin, Vadim Y ^a   Zhang, Xufang ^a   Iserloh, Ulrich ^a   Visser, Michael ^a   Eckhardt, Matthias ^a   Seeberger, Peter H ^a   Danishefsky, Samuel J ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Howard Hughes Medical Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BENZOIC ACID; GLYCOPEPTIDE; LACTOSE; MANNOSE; MANNOSIDE; PENTASACCHARIDE; SUGAR; THIOGLYCOSIDE; TRISACCHARIDE;

ARTICLE; BLOOD GROUP; ENZYME LINKED IMMUNOSORBENT ASSAY; HYDROXYLATION; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; REACTION ANALYSIS; STEREOCHEMISTRY; STRUCTURE ANALYSIS;

EID: 33646491913     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2006.02.080     Document Type: Article

References (72)

1. Burda P., and Aebi M. Biochem. Biophys. Acta 1426 (1999) 239
2. Dwek R.A. Chem. Rev. 96 (1996) 683
3. Dwek R.A. Science 269 (1995) 1234
4. Varki A. Glycobiology 3 (1993) 97
5. Shevinsky L.H., Knowles B.B., Damjanov I., and Solter D. Cell 30 (1982) 697
6. Kobata A. Acc. Chem. Res. 26 (1993) 319
7. Feizi T. Nature 314 (1985) 53
8. Van Dijk W., Turner G.A., and Mackiewicz A. Glycosyl. Dis. 1 (1994) 5
9. Van Dijk W., Van der Stelt M.E., Salera A., and Dente L. Eur. J. Cell Biol. 55 (1991) 143
10. Beitter J.N., Means R.E., and Desrosiers R.C. Nat. Med. 4 (1998) 678
11. Lloyd K.O. Am. J. Clin. Pathol. 87 (1987) 129
12. For a review on the syntheses of O- and N-linked glycopeptides, see:
13. Arsequell G., and Valencia G. Tetrahedron: Asymmetry 8 (1997) 2839
14. Arsequell G., and Valencia G. Tetrahedron: Asymmetry 10 (1999) 3045
15. Pratt M.R., and Bertozzi C.R. Chem. Soc. Rev. 34 (2005) 58
16. Hölemann A., and Seeberger P.H. Curr. Opin. Biotechnol. 15 (2004) 615
17. For the all-chemical and chemoenzymatic synthesis of high mannose-containing N-linked glycopeptides, see, for example:
18. Matsuo I., Nakahara Y., Ito Y., Nukada T., Nakahara Y., and Ogawa T. Bioorg. Med. Chem. 3 (1995) 1455
19. Ito Y., and Ogawa T. J. Am. Chem. Soc. 119 (1997) 5562
20. Guo Z.W., Nakahara Y., and Ogawa T. Angew. Chem. 109 (1997) 1527
21. Guo Z.W., Nakahara Y., and Ogawa T. Angew. Chem., Int. Ed. 36 (1997) 1464
22. Unverzagt C. Carbohydr. Res. 305 (1998) 423
23. Unverzagt C. Angew. Chem. 109 (1997) 2078
24. Unverzagt C. Angew. Chem., Int. Ed. 36 (1997) 1989
25. Unverzagt C. Angew. Chem. 108 (1996) 2507
26. Unverzagt C. Angew. Chem., Int. Ed. 35 (1997) 2350
27. Unverzagt C. Angew. Chem. 106 (1994) 1170
28. Unverzagt C. Angew. Chem., Int. Ed. Engl. 33 (1994) 1102
29. Mitzuno M., Handa K., Iguchi R., Muramoto I., Kawakami T., Aimoto S., Yamamoto K., and Inazu T. J. Am. Chem. Soc. 121 (1999) 284
30. Schmidt R.R., and Kinzy R.R. Adv. Carbohydr. Chem. Biochem. 50 (1994) 21
31. Dudkin V.Y., Miller J.S., and Danishefsky S.J. J. Am. Chem. Soc. 126 (2004) 736
32. Mandal M., Dudkin V.Y., Geng X., and Danishefsky S.J. Angew. Chem., Int. Ed. 43 (2004) 2557
33. Geng X., Dudkin V.Y., Mandal M., and Danishefsky S.J. Angew. Chem., Int. Ed. 43 (2004) 2562
34. Wang Z.-G., Zhang X., Live D., and Danishefsky S.J. Angew. Chem., Int. Ed. 39 (2000) 3652
35. Live D.H., Wang Z.-G., Iserloh U., and Danishefsky S.J. Org. Lett. 3 (2001) 851
36. Wang Z.-G., Zhang X., Visser M., Live D., Zatorski A., Iserloh U., Lloyd K.O., and Danishefsky S.J. Angew. Chem., Int. Ed. 40 (2001) 1728
37. Danishefsky S.J., Hu S., Cirillo P.F., Eckhardt M., and Seeberger P.H. Chem. Eur. J. 3 (1997) 1617
38. Cohen-Anisfeld S.T., and Lansbury P.T. J. Am. Chem. Soc. 115 (1993) 10531
39. Danishefsky S.J., and Bilodeau M.T. Angew. Chem. 108 (1996) 1482
40. Danishefsky S.J., and Bilodeau M.T. Angew. Chem., Int. Ed. 35 (1996) 1380
41. For the general strategy we employ in reaching the 'high mannose' core system, see:. Seeberger P.H., Cirillo P.F., Hu S., Beebe X., Bilodeau M.T., and Danishefsky S.J. Enantiomer 1 (1996) 311
42. Likhosherstov L.M., Novikova O.S., Derevitskaja V.A., and Kochetkov N.K. Carbohydr. Res. 146 (1986) C1
43. Griffith D.A., and Danishefsky S.J. J. Am. Chem. Soc. 112 (1990) 5811
44. Pfitzer K.E., and Mofatt J.G.F. J. Am. Chem. Soc. 87 (1965) 5661
45. Seeberger P., Eckhardt M., Gutteridge C., and Danishefsky S.J. J. Am. Chem. Soc. 119 (1997) 10064
46. With modification of the original procedure from:. Shaban M.A.E., and Jeanloz R.W. Carbohydr. Res. 46 (1976) 138
47. The catalytic use of sodium methoxide in methanol is referred to as the Zemplén de-O-acetylation, see:. Greene T.W., and Wuts P.G.M. Protective Groups in Organic Synthesis (1999), Wiley, New York, NY p 154
48. Dess D.B., and Martin J.C. J. Am. Chem. Soc. 113 (1991) 7277
49. Amann A., Ourisson G., and Luu G.B. Synthesis (1987) 2002
50. Meyers A.I., Comins D.L., Roland D.M., Henning R., and Shimizu K. J. Am. Chem. Soc. 101 (1979) 7104
51. Imperiali B., and O'Connor S.E. Curr. Opin. Chem. Biol. 3 (1999) 643
52. Imperiali B. Acc. Chem. Res. 30 (1997) 452
53. Imperiali B., and O'Connor S.E. Chem. Biol. 3 (1996) 803
54. O'Connor S.E., and Imperiali B. J. Am. Chem. Soc. 119 (1997) 2295
55. Davis J.T., Hirani S., Bartlett C., and Reid B.R. J. Biol. Chem. 269 (1994) 3331
56. O'Connor S.E., and Imperiali B. Chem. Biol. 5 (1998) 427
57. Gigg R. Am. Chem. Soc. Symp. Ser. 39 (1977) 253
58. Wang Z.G., Ito Y., Nakahara Y., and Ogawa T. Bioorg. Med. Chem. Lett. 4 (1994) 2805
59. Danishefsky S.J., Koseki K., Griffith D.A., Gervay J., Peterson J.M., McDonald F.E., and Oriyama T. J. Am. Chem. Soc. 114 (1992) 8331
60. 2O) is needed to dehydrate the initial adduct (amide) into the phthalimide.
61. For a brilliant example featuring the simultaneous removal of 17 benzyl groups, see:. Frick W., Bauer A., Bauer S., Wied S., and Müller G. Biochem. 37 (1998) 13421
62. Iserloh U., Dudkin V., Wang Z.-G., and Danishefsky S.J. Tetrahedron Lett. 43 (2002) 7027
63. Frick W., Bauer A., Bauer J., Wied S., and Müller G. Biochemistry 37 (1998) 13421
64. For analysis of the fine specificities of 11 mouse monoclonal antibodies reactive with H-type 2 blood group determinants see:. Furukawa K., Welt S., Yin B.W.T., Feickert H.-J., Takahashi T., Ueda R., and Lloyd K.O. Mol. Immunol. 27 (1990) 723
65. Actually, these data demonstrate that, in the very least, one of the two H-type 2 determinants in 3 is immunorecognized. They do not prove that both subunits are recognized, although this is presumably the case.
66. Krantz S.B., and Jacobsen L.O. Erythropoietin and the Regulation of Erythropoiesis (1970), University of Chicago Press, Chicago
67. Goldwasser E., and Kung C.K.-H. Proc. Natl. Acad. Sci. U.S.A. 68 (1971) 697
68. Miyake T., Kung C.K.-H., and Goldwasser E. J. Biol. Chem. 252 (1977) 5558
69. Warren J.D., Miller J.S., Keding S.J., and Danishefsky S.J. J. Am. Chem. Soc. 126 (2004) 6576
70. 3CN/TFA gradient. The first C-terminal amino acid was attached to the superacid-lable Fmoc-Rink Amide MBHA resin. The subsequent amino acids, which were introduced were protected as Thr(OtBu) and Asp(Dmab ester). Standard TFA-cleavage, Dmab- and Fmoc-removal (2% hydrazine in MeOH), and acetylation of the N-terminus yielded the desired peptides.
71. Prepared from lactal according to the procedure published by. Schaubach R., Hemberger J., and Kinzy W. Liebigs Ann. Chem. 7 (1991) 607-614
72. Danishefsky S.J., Behar V., Randolph J.T., and Lloyd K.O. J. Am. Chem. Soc. 117 (1995) 5701